Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jabil Inc (JBL) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Jabil Inc vs Health Care Select Sector SPDR Fund — how do they compare? Jabil Inc trades at $367.24 (market cap $37.37B), while Health Care Select Sector SPDR Fund trades at $168.52. The key difference: Jabil Inc pays a 0.09% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.

JBLXLV
Market Cap
$37.37B
Sector
Technology
52-Week High
$385.50$168.44
52-Week Low
$192.49$131.16
Enterprise Value
$39.90B
Dividend Yield
0.09%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Jabil Inc

JBL trades at $368.37, up 9.43% with strong bullish momentum driven by AI infrastructure demand and recent earnings beats. The stock shows robust technical strength with moving averages signaling buy and price approaching resistance at $371. Fundamentally, revenue growth accelerated to $33.6B in 2026 with net profit margin improving to 2.56%, though valuation multiples remain elevated with P/E at 44.63.

Outlook remains positive with analyst consensus target of $448.29 (22% upside) and 50% buy ratings. Key opportunities include projected AI revenue growth to $20B+ by 2027, while risks include competitive pressures and the stock's premium valuation. Recent UBS upgrade to Buy highlights multi-year AI growth cycle potential.

Health Care Select Sector SPDR Fund

XLV, the Health Care Select Sector SPDR ETF, trades at $167.93, down 0.3% on the day, with a bullish technical signal driven by moving averages. The ETF offers broad healthcare exposure with a low expense ratio of 0.08% and a trailing dividend yield of 1.6%, positioning it as a cost-effective defensive play amid market volatility. Recent news highlights strong sector inflows and defensive demand, with earnings from key holdings like UnitedHealth showing resilience despite Medicaid pressures.

The outlook for XLV is positive, supported by its defensive characteristics and institutional interest, though risks include regulatory pressures and sector-specific volatility. Investors may find value in its diversification and steady performance, but should monitor healthcare policy developments and earnings trends for sustained growth.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Jabil Inc

Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.

Read more on JBL

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV